Clinical Trials Directory

Trials / Conditions / Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

6 registered clinical trials studyying Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingLong-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
NCT05697861
Intellia Therapeutics—
WithdrawnEfficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)
NCT04882735
Eidos Therapeutics, a BridgeBio companyPhase 3
CompletedStudy to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With H
NCT04601051
Intellia TherapeuticsPhase 1
WithdrawnEfficacy and Safety of AG10 in Subjects with Transthyretin Amyloid Polyneurophathy
NCT04418024
Eidos Therapeutics, a BridgeBio companyPhase 3
WithdrawnBiomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)
NCT02713880
CENTOGENE GmbH Rostock—
CompletedTRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
NCT03237494
CENTOGENE GmbH Rostock—